ANNUAL REPORT 2006/07
  Tamro in Brief
  CEO's Review
  Corporate Governance
 
  Group Management
  Financial Risk Management
  Corporate Responsibility
  Human Resources
BUSINESS UNITS
FINANCIAL STATEMENTS
  Board of Directors' Report
 
  Board of Directors
  Consolidated Income Statement
  Consolidated Balance Sheet
  Consolidated Cash Flow Statement
  Income Statement of the Parent Company
  Balance Sheet of the Parent Company
  Cash Flow Statement of the Parent Company
  Accounting Principles
Notes to the Financial Statements
  Proposal for Profit Distribution
  Auditors' Report
  Financial Indicators 2002-2006/07
  Calculation of Financial Ratios
  Quarterly Development
  Site Map/
Download Centre
   
 
  suomeksi Suomeksi
  Index Home
  Back Back
  Info Instructions
  Print Print
Notes to the Financial Statement
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 1-10
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 11-20
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 21-30
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 31-44
 
Displaying Notes 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44 out of total 44 notes  
(Figures are in EUR thousands unless otherwise stated) 31 Jan 2007 31 Jan 2006
 
31. INCOME TAXES
 
Income taxes on ordinary activities -2,268 -1,196
Change in deferred taxes -99 -2,555
  -2,367 -3,751
     
 
NOTES TO THE PARENT COMPANY BALANCE SHEET
 
32. FIXED ASSETS
  Intangible assets Tangible assets>
  Intangible
rights
Goodwill Other
capital-
ised
expen-
diture
Advance payments
and construction
in progress
Land areas Buildings Machinery and equipment Other
tangible
assets
Advance payments and con-
struction
in progress
Acquisition value 1 Feb 2006 9,471 39,594 1,708 1,174 928 62,867 32,623 234 51
Increase 173 1,105 754 998 203
Decrease -2,778 -508 -81 -4,600 -7,971
Other changes          
Acquisition value 31 Jan 2007 6,866 39,086 1,627 2,279 928 59,021 25,650 234 254
 
Accumulated depr. 1 Feb 2006 -8,985 -37,968 -1,643 0 0 -27,639 -29,723 0 0
Increase -290 -557 -50 -1,656 -1,059
Decrease 2,777 508 81 4,600 7,948
Other changes          
Accumulated depr. 31 Jan 2007 -6,498 -38,017 -1,612 0 0 -24,695 -22,834 0 0
                   
Value adjustments 1 Feb 2006 - 31 Jan 2007         420 2,355      
                   
Bookvalue 31 Jan 2007 368 1,069 15 2,279 1,348 36,681 2,816 234 254
 
Bookvalue 31 Jan 2006 486 1,626 65 1,174 1,348 37,583 2,900 234 51

33. GROUP COMPANIES
Acquisition value 1 Feb 2006 432,914          
Increase   -6,732          
Acquisition value 31 Jan 2007 426,182          
 
Company Registered office Group share of Parent
company
share of
holding %

Shares owned by
the parent company

holding
and votes %
share-
holders'
equity
Number
of shares
Nominal
value
Book
value
Nomeco A/S Copenhagen, Denmark 100 148,304 100 7,200,000 19,293 197,155
Unikem A/S Copenhagen, Denmark 100 -315 - - - -
Hermedico A/S
Copenhagen, Denmark
100 2,729 - - - -
Forex A/S
Silkeborg, Denmark
100 714 - - - -
Tamro Sweden AB
Gothenburg, Sweden
100 15,590 100 1,000 11 34,418
Tamro AB
Gothenburg, Sweden
100 119,306 - - - -
Tamro SIA
Riga, Latvia
100 11,688 100 215 1,884 1,376
Medinord Oy
Vantaa, Finland
100 436 100 163 163 895
Hansa Pharma SIA
Riga, Latvia
100 2,554 - - - -
Veca Aptieka SIA
Riga, Latvia
100 24 - - - -
Jekabpils Meza Aptieka SIA Riga, Latvia
100 22 - - - -
Riela SIA Riga, Latvia
100 -73 - - - -
Koduapteek OÜ
Tallinn, Estonia 100 -1,089 - - - -
Aptesel OÜ Saue, Estonia 100 3 - - - -
Viimsi Apteek OÜ Viimsi, Estonia 100 10 - - - -
Posti Apteek OÜ Haapsalu, Estonia 100 12 - - - -
Phoenix Pharma Polska Sp.z.o.o. Warsaw, Poland 100 17,632 - - - -
Farmplus Sp.z.o.o.

 

Warsaw, Poland

100 18,378 - - - -
Tamro UAB
Kaunas, Lithuania 100 31,858 100 51,810 6,002 30,537
Karoliniskiu vaistine UAB
Kaunas,Lithuania
100 470 - - - -
Armedikos vaistine group
Kaunas, Lithuania
100 -462 - - - -
Ortofarma UAB Kaunas, Lithuania 100 76 - - - -
Farmasijos Projektai group Kaunas, Lithuania 100 1,181 - - - -
Vogne UAB Klaipeda,Lithuania 100 -370 - - - -
Gintaro vaistine UAB Silute,Lithuania 100 11 - - - -
Ramuciu vaistine UAB Kaunas,Lithuania 100 -667 - - - -
Apokjeden AS
Skårer, Norway 100 123,061 100 1,083,691 13,392 131,328
Apokjeden Distribusjon AS
Skårer, Norway 100 38,028 - - - -
Apotek 1 Norge AS
Skårer, Norway 100 129,872 - - - -
Tamro Eesti AS Tallinn, Estonia 100 12,196 100 5,500 352 530
Tamro Finance Oy

Vantaa, Finland

100 34,642 99 99 990 29,700
Apteekkarien Osuuskunta Vantaa, Finland 100 2,200 100 1,990 33 33
Tamro Russia Oy Vantaa, Finland 100 157 100 100,000 100 170
               
Other subsidiaries, incl. non-operational       40
              426,182
               
34. OTHER SHARES AND PARTICIPATIONS
    Book value
Golf shares   83
OMX Plc   27
Telephone company shares etc.   7
Real estate and other shares   29
    146
     
  31 Jan 2007 31 Jan 2006
35. LONG-TERM RECEIVABLES
     
Deferred income tax asset 376 475
     
36. SHORT-TERM RECEIVABLES
     
Accounts receivable 43,276 46,769
Short-term receivables from Group companies 135,936 129,707
Loan receivables 1 2,847
Other short-term receivables 2,519 9,671
  181,732 188,994
     
Short-term receivables from Group companies    
  Accounts receivable 1,158 1,269
  Prepaid expenses and accrued income 422 491
  Loan receivables 134,356 127,481
  Other short-term receivables 0 466
  135,936 129,707
     
37. PREPAID EXPENSES AND ACCRUED INCOME
     
Income tax receivable 1,726 2,314
Financial items 28 6,599
Prepaid expenses 1 433
Other income 764 325
Total 2,519 9,671

38. CHANGES IN SHAREHOLDERS' EQUITY
  Share capital Share premium account Revaluation
reserve
Retained earnings Total equity
Equity 1 Feb 2005 114,837 5,640 1,093 336,051 457,621
Dividend -121,366 -121,366
Other change         0
Equity 31 Jan 2006 114,837 5,640 1,093 223,736 345,306
           
Dividend       -68,697 -68,697
Net profit for the year       58,697 58,697
Equity 31 Jan 2007 114,837 5,640 1,093 213,736 335,306
           
  31 Jan 2007 31 Jan 2006
39. ACCUMULATED DEPRECIATION DIFFERENCE
Accelerated depreciation    
  Intangible rights 123 134
  Goodwill 1,069 1,626
  Other capitalised expenditure 0 2
  Buildings 23,799 24,586
  Machinery and equipment -424 -474
  24,567 25,874
     
40. OBLIGATORY RESERVES
     
Pension reserves 357 357
Other obligatory reserves 234 333
  591 690
     
41. SHORT-TERM LIABILITIES
     
Loans from financial institutions and interest bearing advance payments 21,979 40,914
Accounts payable 127,658 116,449
Liabilities to group companies 230,357 214,668
Accrued expenses and deferred income 9,828 9,359
Other current liabilities 2,463 2,590
  392,285 383,980
     
Liabilities to Group companies    
  Accounts payable 2,414 425
  Accrued liabilities 231 44
  Other short-term liabilities 227,712 214,199
  230,357 214,668
     
42. ACCRUED EXPENSES AND DEFERRED INCOME
     
Personnel expenses 7,304 7,627
Financial items 117 104
Other accrued expenses and deferred income 2,407 1,628
 
Total 9,828 9,359

 
OTHER NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS
 
43. CONTINGENT LIALIBILITIES 31 Jan 2007 31 Jan 2006
     
Mortgages (1)    
 For own debts 841 841
 
Guarantees
  For subsidiaries 57,846 65,241
  For debts of others 319 -
  58,165 65,241
Other commitments
  Leasing commitments
    Next year 1,250 1,202
    Over one year 1,041 1,701
  Rent commitments 253 316
  2,544 3,219
     
(1) Parent company's liabilities, secured by mortgages    
Parent company has guaranteed the Commercial papers issued by Tamro Finance Ltd. In Finland and Sweden. The Commercial paper programme in Finland amounts to EUR 300,000,000 and in Sweden SEK 1,000,000,000. There were no outstanding amounts in Finland nor in Sweden at the end of financial year.
 
Parent company has given its subsidiaries and on their behalf a Letter of Comfort type commitments.
 
44. DERIVATIVE FINANCIAL INSTRUMENTS 31 Jan 2007 31 Jan 2006
     
Derivatives - notional amounts    
Currency instruments    
  Currency forward contracts 72,174 84,829
 
Derivatives - market value
Currency instruments
  Currency forward contracts 0 81
     
The notional amounts of derivatives summarised here do not represent amounts actually exchanged between the parties and are thus not a measure of the parent company's derivatives-related exposure. According to the Finance Policy derivatives are used only to hedge the underlying business.
 
 
Displaying Notes 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44 out of total 44 notes  
  Tamro Web Annual Report 2006/07. Published 9 May 2007. Copyright © Tamro Corporation 2007. All rights reserved.